Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas P Burris

Showing results (111-120 of 167) with videos related to

Pageof 17
Sort By:
Nature Structural & Molecular Biology|November 27, 2007
Identification of heme as the ligand for the orphan nuclear receptors REV-ERBalpha and REV-ERBbetaSrilatha Raghuram, Keith R Stayrook, Pengxiang Huang, et al.
Molecular Pharmacology|August 21, 2024
The Estrogen Receptor-Related Orphan Receptors Regulate Autophagy through TFEBMcKenna Losby, Matthew Hayes, Aurore Valfort, et al.
Molecular Pharmacology|November 6, 2009
The benzenesulfoamide T0901317 [N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide] is a novel retinoic acid receptor-related orphan receptor-alpha/gamma inverse agonistNaresh Kumar, Laura A Solt, Juliana J Conkright, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2003
Helix-stabilized cyclic peptides as selective inhibitors of steroid receptor-coactivator interactionsAnne-Marie Leduc, John O Trent, James L Wittliff, et al.
ACS Chemical Biology|April 13, 2022
Antihyperlipidemic Activity of Gut-Restricted LXR Inverse AgonistsKristine Griffett, Matthew Hayes, Gonzalo Bedia-Diaz, et al.
Structure (London, England : 1993)|October 16, 2010
Hydrogen/deuterium exchange reveals distinct agonist/partial agonist receptor dynamics within vitamin D receptor/retinoid X receptor heterodimerJun Zhang, Michael J Chalmers, Keith R Stayrook, et al.
Plos One|April 12, 2019
Pharmacological activation of the nuclear receptor REV-ERB reverses cognitive deficits and reduces amyloid-β burden in a mouse model of Alzheimer's diseaseDeborah A Roby, Fernanda Ruiz, Bailey A Kermath, et al.
Nature Communications|November 22, 2022
Structural basis of synthetic agonist activation of the nuclear receptor REV-ERBMeghan H Murray, Aurore Cecile Valfort, Thomas Koelblen, et al.
JCI Insight|September 8, 2017
REV-ERBα ameliorates heart failure through transcription repressionLilei Zhang, Rongli Zhang, Chih-Liang Tien, et al.
Molecular Pharmacology|November 21, 2007
Regulation of human 3 alpha-hydroxysteroid dehydrogenase (AKR1C4) expression by the liver X receptor alphaKeith R Stayrook, Pamela M Rogers, Rajesh S Savkur, et al.
Pageof 17

Showing results (111-120 of 167) with videos related to

Sort By:
Pageof 17
Nature Structural & Molecular Biology|November 27, 2007
Identification of heme as the ligand for the orphan nuclear receptors REV-ERBalpha and REV-ERBbetaSrilatha Raghuram, Keith R Stayrook, Pengxiang Huang, et al.
Molecular Pharmacology|August 21, 2024
The Estrogen Receptor-Related Orphan Receptors Regulate Autophagy through TFEBMcKenna Losby, Matthew Hayes, Aurore Valfort, et al.
Molecular Pharmacology|November 6, 2009
The benzenesulfoamide T0901317 [N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide] is a novel retinoic acid receptor-related orphan receptor-alpha/gamma inverse agonistNaresh Kumar, Laura A Solt, Juliana J Conkright, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2003
Helix-stabilized cyclic peptides as selective inhibitors of steroid receptor-coactivator interactionsAnne-Marie Leduc, John O Trent, James L Wittliff, et al.
ACS Chemical Biology|April 13, 2022
Antihyperlipidemic Activity of Gut-Restricted LXR Inverse AgonistsKristine Griffett, Matthew Hayes, Gonzalo Bedia-Diaz, et al.
Structure (London, England : 1993)|October 16, 2010
Hydrogen/deuterium exchange reveals distinct agonist/partial agonist receptor dynamics within vitamin D receptor/retinoid X receptor heterodimerJun Zhang, Michael J Chalmers, Keith R Stayrook, et al.
Plos One|April 12, 2019
Pharmacological activation of the nuclear receptor REV-ERB reverses cognitive deficits and reduces amyloid-β burden in a mouse model of Alzheimer's diseaseDeborah A Roby, Fernanda Ruiz, Bailey A Kermath, et al.
Nature Communications|November 22, 2022
Structural basis of synthetic agonist activation of the nuclear receptor REV-ERBMeghan H Murray, Aurore Cecile Valfort, Thomas Koelblen, et al.
JCI Insight|September 8, 2017
REV-ERBα ameliorates heart failure through transcription repressionLilei Zhang, Rongli Zhang, Chih-Liang Tien, et al.
Molecular Pharmacology|November 21, 2007
Regulation of human 3 alpha-hydroxysteroid dehydrogenase (AKR1C4) expression by the liver X receptor alphaKeith R Stayrook, Pamela M Rogers, Rajesh S Savkur, et al.
Pageof 17